Vimian Group ABVIMGF 76 Gross Margin % is 69.91% as of Mar. 2026, which is 1% above its 10-year median of 68.91. GuruFocus rates VIMGF with a GF Score™ of 76/100 and a GF Value™ of $3.24. The stock has 2 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Vimian Group AB ranks better than 73.33% on this metric.
The historical rank and industry rank for Vimian Group AB's Gross Margin % or its related term are showing as below:
VIMGF'
s Gross Margin % Range Over the Past 10 Years
Min: 56.76 Med: 68.91 Max: 70.87
Current: 69
During the past 9 years, the highestGross Margin % of Vimian Group AB was 70.87%. The lowest was 56.76%. And the median was 68.91%.
VIMGF's Gross Margin % is ranked better than 73.33% of 195
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.97
vs VIMGF: 69.00
Vimian Group AB had a gross margin of 69.91% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vimian Group AB was 0.50% per year.
Vimian Group AB (OTCPK:VIMGF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vimian Group AB had a gross margin of 69.91% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vimian Group AB Gross Margin % Related Terms
Vimian Group AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vimian Group AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VIMGF vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Vimian Group AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimian Group AB Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vimian Group AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vimian Group AB (VIMGF) has a Gross Margin % of 69.91% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Vimian Group AB and its competitors. This is near median its historical median of 68.91. Over the past decade, Vimian Group AB's Gross Margin % has ranged from 56.76 to 70.87. According to the industry distribution chart, Vimian Group AB ranks #52 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 26.7%.
Is Vimian Group AB's Gross Margin % too high?
Vimian Group AB's current Gross Margin % of 69.91% is near median its 10-year median of 68.91. Over the past 10 years, this metric has ranged from a low of 56.76 to a high of 70.87. The Medical Diagnostics & Research industry median Gross Margin % is 50.97. Vimian Group AB's value of 69.91% is 37.2% above this industry median. Based on the distribution chart, Vimian Group AB ranks #52 out of 195 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Vimian Group AB has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimian Group AB ranks #52 out of 195 companies for Gross Margin %. This puts Vimian Group AB in the upper half of its industry. The industry median Gross Margin % is 50.97. Vimian Group AB's value of 69.91% is 37.2% above this benchmark. Historically, Vimian Group AB's own Gross Margin % has ranged from 56.76 to 70.87 over the past decade. While the company's 10-year median is 68.91 vs. the industry median of 50.97, Vimian Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.97, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimian Group AB's current Gross Margin % of 69.91% is 37.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vimian Group AB and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimian Group AB's current Gross Margin % is 69.91%, which is near median its own 10-year median of 68.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (VIMGF) has a current Gross Margin % of 69.91%. The stock's GF Value™ is $3.24, compared to a current price of $2.77 — trading 14.5% below its estimated fair value. The current Gross Margin % is 69.91%, which is near median its 10-year median of 68.91 and 37.2% above the Medical Diagnostics & Research industry median of 50.97. Vimian Group AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vimian Group AB (VIMGF), the current Gross Margin % is 69.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimian Group AB (VIMGF) Overvalued in 2026?
Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued.
The current stock price of $2.77 is trading 14.5% below its estimated GF Value™ of $3.24.
Key valuation signals for VIMGF:
Gross Margin %: 69.91% (near median its 10-year median of 68.91)
GF Value™: $3.24 vs. price of $2.77 (14.5% below fair value)
Industry Position: 37.2% above the Medical Diagnostics & Research median (#52 of 195)
No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
76GF Score
Get the complete analysis for VIMGF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VIMGF has been successfully added to your 
